MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MXCT is expected to report earnings to rise 92.25% to -7 cents per share on August 12
Q2'26
Est.
$-0.08
Q1'26
Beat
by $0.04
Q4'25
Missed
by $0.01
Q3'25
Missed
by $0.01
Q2'25
Missed
by $0.02
The last earnings report on May 12 showed earnings per share of -3 cents, beating the estimate of -7 cents. With 434.06K shares outstanding, the current market capitalization sits at 126.94M.